We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

100 hedge funds and large institutions have $589M invested in Albireo Pharma Inc in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less capital invested

Capital invested by funds: $621M → $589M (-$31.8M)

7% less funds holding

Funds holding: 107 → 100 (-7)

25% less call options, than puts

Call options by funds: $2.63M | Put options by funds: $3.52M

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
100
Holders Change
-7
Holders Change %
-6.54%
% of All Funds
1.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
40
Reduced
34
Closed
13
Calls
$2.63M
Puts
$3.52M
Net Calls
-$883K
Net Calls Change
+$3.11M

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$11.6M
2
State Street
State Street
Massachusetts
+$8.12M
3
CC
Chicago Capital
Illinois
+$2.51M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.39M
5
PIM
Platinum Investment Management
Australia
+$2.33M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$6.93M
2
APM
Avidity Partners Management
Texas
-$4.69M
3
AG
Artal Group
Luxembourg
-$3.69M
4
N
Nuveen
North Carolina
-$3.26M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$3.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
26
Birchview Capital
Vermont
$3.91M +$701K +19,000 +21%
ECM
27
Endurant Capital Management
California
$3.64M +$2.25M +60,883 +144%
SB
28
Samsara BioCapital
California
$3.52M – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.28M +$454K +12,293 +15%
HA
30
Heartland Advisors
Wisconsin
$2.47M – – –
PIM
31
Platinum Investment Management
Australia
$2.23M +$2.33M +63,121 New
Citigroup
32
Citigroup
New York
$2.15M +$2.13M +57,679 +1,670%
N
33
Nuveen
North Carolina
$2.11M -$3.26M -88,239 -60%
William Blair & Company
34
William Blair & Company
Illinois
$2.1M +$205K +5,552 +10%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$1.83M +$595K +16,104 +45%
PPA
36
Parametric Portfolio Associates
Washington
$1.77M +$567K +15,368 +44%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$1.74M +$1.54M +41,775 +553%
Charles Schwab
38
Charles Schwab
California
$1.51M +$28.9K +782 +2%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$1.42M -$763K -20,660 -33%
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.23M +$22.2K +600 +2%
AA
41
ALPS Advisors
Colorado
$1.22M +$9.45K +256 +0.7%
Victory Capital Management
42
Victory Capital Management
Texas
$1.21M -$58.7K -1,590 -4%
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$1.13M – – –
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$1.1M -$14.8K -400 -1%
EGM
45
Engineers Gate Manager
New York
$1.07M -$213K -5,762 -16%
Deutsche Bank
46
Deutsche Bank
Germany
$1.01M -$37.8K -1,023 -3%
Los Angeles Capital Management
47
Los Angeles Capital Management
California
$988K -$411K -11,130 -28%
UBS Group
48
UBS Group
Switzerland
$987K +$1.03M +27,911 +31,012%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$955K -$118K -3,196 -11%
Man Group
50
Man Group
United Kingdom
$954K +$1.29K +35 +0.1%
1
2
3 4 5

ALBO Hedge Fund Activity: Q1 2021 in Review

100 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2021, worth a combined $589M — down 5.1% from $621M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of ALBO and 6 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 40 added.

The largest buyer was Rice Hall James & Associates, adding an estimated $11.6M. The largest seller was Marshall Wace, cutting an estimated $6.93M.

  • 100 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2021, down from 107 in Q4 2020.
  • Funds reported $589M of Albireo Pharma Inc stock for Q1 2021, down 5.1% quarter-over-quarter.
  • 6 funds opened new Albireo Pharma Inc positions in Q1 2021 and 13 closed out, a net change of -7 holders.
  • The largest Albireo Pharma Inc buyer in Q1 2021 was Rice Hall James & Associates, an estimated $11.6M added.
  • The largest Albireo Pharma Inc seller in Q1 2021 was Marshall Wace, an estimated $6.93M sold.

Based on aggregated 13F filings for Q1 2021.